COVID-19 Vaccine Storage Considerations

The original webcast served as a COVID-19 vaccination primer that can be used by all types of healthcare workers (HCWs) to help them prepare for Operation Warp Speed and the mass vaccination efforts in the United States. This section of the webcast focused on an vaccine storag...

COVID-19 Vaccination: Logistics, Logistics, Logistics

The original webcast served as a COVID-19 vaccination primer that can be used by all types of healthcare workers (HCWs) to help them prepare for Operation Warp Speed and the mass vaccination efforts in the United States. This section of the webcast focused on an COVID-19 vacci...

COVID-19 Vaccine Implementation

The original webcast served as a COVID-19 vaccination primer that can be used by all types of healthcare workers (HCWs) to help them prepare for Operation Warp Speed and the mass vaccination efforts in the United States. This section of the webcast focused on vaccine implement...

Emerging Vaccines Overview

The original webcast served as a COVID-19 vaccination primer that can be used by all types of healthcare workers (HCWs) to help them prepare for Operation Warp Speed and the mass vaccination efforts in the United States. This section of the webcast focused on an emerging vacci...

A Shot in The Dark: COVID-19 Vaccine Update

This webcast served as a COVID-19 vaccination primer that can be used by all types of healthcare workers (HCWs) to help them prepare for Operation Warp Speed and the mass vaccination efforts in the United States. This webcast is the first in a series of updates that the SCCM w...

IDSA Resources: Pharmacology

SCCM’s COVID-19 Rapid Resource Center now links to pertinent content from the Infectious Diseases Society of America (IDSA) COVID-19 Real-Time Learning Network. These resources are categorized as Pharmacology

Cytokine Storm and ARDS - Comparison of Corticosteroid Dosing Strategies

This resource details how to manage cytokine storm and ARDS by comparing corticosteriod dosing strategies for COVID-19 patients. This is SCCM curated COVID-19 microlearning content.

Do you have any experience with tocilizumab and related drugs? What is your impression of them?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on December 9, 2020.

How do we prevent VTEs and how do we survey for them? Should patients receive standard prophylaxis? Should all ventilated patients receive full-dose anticoagulation? What are your practices and how have you approached this at your center?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on December 9, 2020.

What is your local practice for using Remdesivir in the ICU?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on December 9, 2020.

Is the standard 6 milligrams of dexamethasone for up to 10 days the only option? Do all patients need this or is there any evidence for trying something different? Has there been any experience with using a higher dexamethasone dose?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on December 9, 2020.

What medication adjuncts can clinicians use for the patient with severe hypoxemia who is receiving 100% oxygen but only getting an oxygen reading of 90%? What are some strategies clinicians can use to reduce some of these difficulties?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on December 9, 2020.

CDC Resources: Pharmacology

SCCM’s COVID-19 Rapid Resource Center now links to pertinent content from the Centers for Disease Control and Prevention (CDC). These resources are categorized as Pharmacology

Thromboembolism, Hypercoagulopathy, and Antiphospholipid Antibodies in Critically Ill Coronavirus Disease 2019 Patients: A Before and After Study of Enhanced Anticoagulation

From Critical Care Explorations In this study, the authors sought to determine the prevalence of thrombotic events, functional coagulation tests, inflammatory biomarkers, and antiphospholipid antibodies before and after enhanced anticoagulation in critically ill coronavir...

Propofol-Associated Hypertriglyceridemia in Coronavirus Disease 2019 Versus Noncoronavirus Disease 2019 Acute Respiratory Distress Syndrome

From Critical Care Explorations In this study, the authors found that patients with coronavirus disease 2019 acute respiratory distress syndrome experienced a higher rate of propofol-associated hypertriglyceridemia than noncoronavirus disease 2019 acute respiratory distr...

Clinical Outcomes With the Use of Prophylactic Versus Therapeutic Anticoagulation in Coronavirus Disease 2019

From Critical Care Explorations In this study, the authors found an increase in inhospital mortality was observed among patients on preemptive therapeutic anticoagulation.

A Propensity-Matched Cohort Study of Tocilizumab in Patients With Coronavirus Disease 2019

From Critical Care Explorations The authors assessed the impact of tocilizumab therapy and found that it was associated with significantly improved survival in coronavirus disease 2019 patients.

Editorial: Coronavirus Disease 2019 Acute Respiratory Failure: Almitrine Drug Resuscitation or Resuscitating Patients by Almitrine?

From Critical Care Medicine In this editorial, the author discusses the seeming benefits of using almitrine for severe hypoxia in patients with coronavirus disease 19 induced acute respiratory distress syndrome.

Delirium Incidence, Duration, and Severity in Critically Ill Patients With Coronavirus Disease 2019

From Critical Care Explorations The authors found that mechanical ventilation was significantly associated with odds of delirium even after adjustment for sedatives.

Clinical Pharmacists: An Invaluable Part of the Coronavirus Disease 2019 Frontline Response

From Critical Care Explorations The authors describe how clinical pharmacists fulfilled an essential service during the coronavirus pandemic by working to ensure the best possible outcomes for the patients they served on the frontline.